rs199510610
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_006440.5(TXNRD2):c.656G>C(p.Gly219Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000206 in 1,613,864 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G219R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006440.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial glucocorticoid deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- glucocorticoid deficiency 5Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152184Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000317 AC: 79AN: 249562 AF XY: 0.000288 show subpopulations
GnomAD4 exome AF: 0.000184 AC: 269AN: 1461562Hom.: 3 Cov.: 31 AF XY: 0.000173 AC XY: 126AN XY: 727112 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000414 AC: 63AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The c.656G>C (p.G219A) alteration is located in exon 8 (coding exon 8) of the TXNRD2 gene. This alteration results from a G to C substitution at nucleotide position 656, causing the glycine (G) at amino acid position 219 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Primary dilated cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at